The gene is well-recognized in the pathogenesis of chronic myeloid leukemia (CML), where translocation of chromosomes 22 and 9 creates the BCR-ABL1 fusion gene (Quintás-Cardama and Cortes, 2006). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.